Cynthia J. Dieter - 01 Nov 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Accounting Officer
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
01 Nov 2022
Net transactions value
$0
Form type
4
Filing time
03 Nov 2022, 17:16:09 UTC
Previous filing
24 Jun 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +13,141 +71% $0.000000 31,721 01 Nov 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 3,968 01 Nov 2022 Common Stock 3,968 $28.35 Direct F2
holding NEO Stock Option (Right to Buy) 7,034 01 Nov 2022 Common Stock 7,034 $53.17 Direct F3
holding NEO Stock Option (Right to Buy) 22,805 01 Nov 2022 Common Stock 22,805 $21.41 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On November 1, 2022, Ms. Dieter was granted 13,141 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
F2 On June 22, 2020, Ms. Dieter was granted 3,968 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3 On March 2, 2021, Ms. Dieter was granted 7,034 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F4 On March 1, 2022, Ms. Dieter was granted 22,805 stock options. These options vest ratably over the first four anniversary dates of the grant date.